- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2005-003166-42.
Displaying page 1 of 1.
| EudraCT Number: 2005-003166-42 | Sponsor Protocol Number: CSTI571BDE55 | Start Date*: 2005-12-27 | |||||||||||
| Sponsor Name:University of Leipzig | |||||||||||||
| Full Title: Palliative Chemotherapy (2nd line) with Imatinib (GlivecTM) in Patients with Bile Duct Cancer. | |||||||||||||
| Medical condition: Patients with histologically proven adenocarcinoma of the gallbladder/bile duct (not papillary cancer) in an advanced stage, who have not responded to a first line chemotherapy. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.